Evidence map›Paper›PMID 35065613›Full record

ReviewBMC infectious diseases2022

Low incidence of COVID-19 case severity and mortality in Africa; Could malaria co-infection provide the missing link?

Silas Acheampong Osei, Robert Peter Biney, Alberta Serwah Anning, Lydia Nkuah Nortey, George Ghartey-Kwansah

Open access · goldAbstract readReview
In one paragraph

Review in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 2 pooled it
17.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 2 syntheses or guidelines pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Circulation of SARS-CoV-2 and Co-Infection withInfectious disease reports · 2025
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Narrative Review Explaining the Role ofInfectious disease reports · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Association of specificFrontiers in immunology · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. COVID-19 and Diarylamidines: The Parasitic Connection.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Silas Acheampong OseiSchool of Pharmacy and Pharmaceutical Sciences, University of Cape Coast, Cape Coast, Ghana.
Robert Peter BineySchool of Pharmacy and Pharmaceutical Sciences, University of Cape Coast, Cape Coast, Ghana.
Alberta Serwah AnningDepartment of Biomedical Sciences, University of Cape Coast, Cape Coast, Ghana.
Lydia Nkuah NorteyDepartment of Biomedical Sciences, University of Cape Coast, Cape Coast, Ghana.
George Ghartey-KwansahDepartment of Biomedical Sciences, University of Cape Coast, Cape Coast, Ghana. george.ghartey-kwansah@ucc.edu.gh.
University of Cape Coast · GH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite reports of malaria and coronavirus diseases 2019 (COVID-19) co-infection, malaria-endemic regions have so far recorded fewer cases of COVID-19 and deaths from COVID-19, indicating a probable protection from the poor outcome of COVID-19 by malaria. On the contrary, other evidence suggests that malaria might contribute to the death caused by COVID-19. Hence, this paper reviewed existing evidence hypothesizing poor outcome or protection of COVID-19 patients when co-infected with malaria.

methodsPRISMA guidelines for systematic review were employed in this study. Published articles from December 2019 to May 2021on COVID-19 and malaria co-infection and outcome were systematically searched in relevant and accessible databases following a pre-defined strategy. Studies involving human, in vivo animal studies, and in vitro studies were included.

resultsTwenty three (23) studies were included in the review out of the 3866 records identified in the selected scientific databases. Nine (9) papers reported on co-infection of COVID-19 and malaria. Five (5) papers provided information about synergism of malaria and COVID-19 poor prognosis, 2 papers reported on syndemic of COVID-19 and malaria intervention, and 7 studies indicated that malaria protects individuals from COVID-19.

conclusionsLow incidence of COVID-19 in malaria-endemic regions supports the hypothesis that COVID-19 poor prognosis is prevented by malaria. Although further studies are required to ascertain this hypothesis, cross-immunity and common immunodominant isotopes provide strong evidence to support this hypothesis. Also, increase in co-inhibitory receptors and atypical memory B cells indicate synergy between COVID-19 and malaria outcome, though, more studies are required to make a definite conclusion.

Indexed as

CoinfectionCOVID-19MalariaAfricaAnimalsHumansIncidenceMemory B CellsSARS-CoV-2COVID-19MalariaMalaria-COVID 19 co-infectionPlasmodium falciparumSARS-CoV-2

Identifiers

PMID35065613
PMCPMC8783581
OpenAlexW4206992981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.